On the other hand, little information has been published on the liver of Ku70-deficient mice, and only one report suggests that Ku70-deficient mice treated with an alkylating agent will rapidly develop hepatocellular carcinomas [121]. This evidence concerns the gene XRCC6 and hepatocellular carcinoma.